Mylan to merge with Upjohn

Mylan NV is merging with Upjohn, the off-patented branded and generic established medicines business of Pfizer Inc. Pfizer shareholders would own 57 percent of the combined company while Mylan would have 43 percent. Upjohn’s brands include Lipitor, Celebrex and Viagra while Mylan is known for the Epipen.

DealsNorth AmericaUSHealthcareBriefs